Location History:
- Saiguede, FR (1998)
- Saint-Lys, FR (2000 - 2022)
- Saint Lys, FR (2023)
Company Filing History:
Years Active: 1998-2023
Title: Patrick Frayssinet: Innovator in Cancer Treatment
Introduction
Patrick Frayssinet is a notable inventor based in Saint-Lys, France. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 5 patents, Frayssinet's work focuses on developing advanced therapeutic solutions for cancer patients.
Latest Patents
Frayssinet's latest patents include groundbreaking inventions such as autologous cancer vaccines. This invention involves a method for producing a cancer vaccine by extracting proteins from a serum or plasma sample obtained from a cancer patient. The extracted proteins are then brought into contact with hydroxyapatite and/or tricalcium phosphate particles. Another significant patent relates to a hydroxyapatite and/or tricalcium phosphate powder that has undergone sintering at temperatures between 400°C and 600°C. This powder is intended for use as an anti-tumor auto-vaccine, particularly for treating various types of tumors, including osteosarcoma and melanoma. Additionally, this invention covers a drug combination that includes the composition and at least one second therapeutic agent.
Career Highlights
Throughout his career, Patrick Frayssinet has worked with several companies, including Bioland Ltd. and Urodelia. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.
Collaborations
Frayssinet has collaborated with notable coworkers such as Nicole Rouquet and Alain Lerch. These partnerships have played a crucial role in advancing his research and patent developments.
Conclusion
Patrick Frayssinet is a distinguished inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative patents reflect his commitment to advancing medical science and improving therapeutic options for cancer patients.